Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Genetic evidence implicating circulating lipids and lipid drug targets in pterygium. Local targets link to admitted publications; unresolved targets remain external evidence.
Conjunctival and limbal conjunctival autograft vs. amniotic membrane graft in primary pterygium surgery: a 30-year comprehensive review
10.1007/s40123-023-00689-x · 2023 · External reference
Prevalence and risk factors of pterygium: a systematic review and meta-analysis
10.1016/j.survophthal.2018.03.001 · 2018 · External reference
Prevalence of and Racial Differences in Pterygium
10.1016/j.ophtha.2012.02.009 · 2012 · External reference
Prevalence of pterygium and its associated factors among adults aged 18 years and above in Gambella town, Southwest Ethiopia, May 2019
10.1371/journal.pone.0237891 · 2020 · External reference
Prevalence of pterygium in a population in Northern Japan: the Locomotive Syndrome and Health Outcome in Aizu Cohort Study
2013 · External reference
The prevalence and recurrence risk of bare sclera pterygium surgery in the United States
10.1016/j.jtos.2023.05.006 · 2023 · External reference
10.1038/s41433-020-0786-3
10.1038/s41433-020-0786-3 · External reference
Conjunctival autograft for pterygium
2016 · External reference
Pterygium and ultraviolet radiation: a positive correlation
10.1136/bjo.68.5.343 · 1984 · External reference
Pterygium: an update on pathophysiology, clinical features, and management
2021 · External reference
Conjunctival autograft versus amniotic membrane transplantation for treatment of pterygium: findings from a cochrane systematic review
10.1016/j.ajo.2017.07.004 · 2017 · External reference
10.1038/s41433-020-0786-3
10.1038/s41433-020-0786-3 · External reference
Profile of tear lipid mediator as a biomarker of inflammation for meibomian gland dysfunction and ocular surface diseases: standard operating procedures
10.1016/j.jtos.2020.09.008 · 2022 · External reference
Tear eicosanoids in healthy people and ocular surface disease
10.1038/s41598-018-29568-3 · 2018 · External reference
Lipid-based therapy for ocular surface inflammation and disease
10.1016/j.molmed.2015.10.001 · 2015 · External reference
Hyperlipidemia induces meibomian gland dysfunction
10.1016/j.jtos.2019.06.002 · 2019 · External reference
Prevalence and risk factors for pterygium: a cross-sectional study in Han and Manchu ethnic populations in Hebei, China
10.1136/bmjopen-2018-025725 · 2019 · External reference
High HDL-C and high LDL-C are risk factors of pterygium in a population-based cross-sectional study in Southern China: the Dongguan Eye Study
10.1136/bmjopen-2021-058649 · 2022 · External reference
The correlation of routine hematological indices with pterygium
2019 · External reference
Does systemic inflammation play a role in patients with pterygium
10.1007/s10792-020-01414-4 · 2020 · External reference
The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable Mendelian-randomization study
10.1016/j.ebiom.2023.104537 · 2023 · External reference
Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies
10.1136/bmj.j2376 · 2017 · External reference
“Mendelian randomization”: an approach for exploring causal relations in epidemiology
10.1016/j.puhe.2016.12.033 · 2017 · External reference
The use of Mendelian randomisation to identify causal cancer risk factors: promise and limitations
10.1002/path.5421 · 2020 · External reference
Vitamin D and multiple health outcomes: an umbrella review of observational studies, randomized controlled trials, and mendelian randomization studies
10.1093/advances/nmab142 · 2022 · External reference
Association between genetically proxied inhibition of HMG-CoA reductase and epithelial ovarian cancer
10.1001/jama.2020.0150 · 2020 · External reference
Comparing the relationships of genetically proxied PCSK9 inhibition with mood disorders, cognition, and dementia between men and women: a drug‐target mendelian randomization study
10.1161/jaha.122.026122 · 2022 · External reference
10.1038/s41467-020-16969-0
10.1038/s41467-020-16969-0 · External reference
10.1016/s2213-8587(16)30396-5
10.1016/s2213-8587(16)30396-5 · External reference
10.1016/j.jacc.2022.05.041
10.1016/j.jacc.2022.05.041 · External reference
10.1002/gepi.21758
10.1002/gepi.21758 · External reference
10.1002/gepi.21965
10.1002/gepi.21965 · External reference
10.1007/s10654-017-0255-x
10.1007/s10654-017-0255-x · External reference
10.1093/ije/dyx102
10.1093/ije/dyx102 · External reference
High-fat diet induces inflammation of meibomian gland
10.1167/iovs.62.10.13 · 2021 · External reference
High-fat diet induces dry eye-like ocular surface damages in murine
10.1016/j.jtos.2020.02.009 · 2020 · External reference
10.1126/science.1059344
10.1126/science.1059344 · External reference
10.1021/ar3003267
10.1021/ar3003267 · External reference
Inhibiting PCSK9 - biology beyond LDL control
10.1038/s41574-018-0110-5 · 2018 · External reference
Statins in ophthalmology
10.1016/j.survophthal.2019.01.013 · 2019 · External reference
Total cholesterol and lipoprotein composition are associated with dry eye disease in Korean women
10.1186/1476-511x-12-84 · 2013 · External reference
Association between statin use and uveitis: results from the Pacific Ocular Inflammation study
10.1016/j.ajo.2015.01.009 · 2015 · External reference
Clinical and immunological responses in ocular demodecosis
10.3346/jkms.2011.26.9.1231 · 2011 · External reference
Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures
10.1167/iovs.13-12132 · 2013 · External reference
Tear biomarkers in dry eye disease: progress in the last decade
10.4103/ijo.ijo_2981_22 · 2023 · External reference
10.1002/jcb.23173
10.1002/jcb.23173 · External reference
PCSK9 inhibitors for prevention of atherosclerotic cardiovascular disease
10.1016/j.jacl.2018.06.013 · 2018 · External reference
10.1093/cvr/cvz003
10.1093/cvr/cvz003 · External reference
The pharmacology of statins
10.1016/j.phrs.2014.03.002 · 2014 · External reference
Orbital myositis secondary to statin therapy
10.5694/mja15.00503 · 2015 · External reference
Coenzyme q10 and statin-induced mitochondrial dysfunction
2010 · External reference
